fibrinogen has been researched along with Liver Failure, Acute in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 9 (69.23) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Dong, L; Dou, G; Liu, T; Wan, Y; Wang, X; Wu, C; Yang, Y; Yu, M; Zhai, H | 1 |
| Bechmann, LP; Best, J; Buechter, M; Canbay, A; Gerken, G; Gieseler, RK; Katsounas, A; Kreimeyer, H; Manka, P; Sowa, JP | 1 |
| Huang, J; Liu, Y; Luo, X; Ning, Q; Shen, G; Wan, X; Wang, H; Xi, D; Yan, W; Yu, H | 1 |
| Luo, X; Ning, Q; Wang, M; Xi, D; Ye, H | 1 |
| Chen, J; Li, GQ; Wu, YZ; Xu, GL; Yang, F; Zheng, LX | 1 |
| Amir, AZ; Avitzur, Y; Cattral, M; Cutz, E; De Angelis, M; Fecteau, A; Ghanekar, A; Grant, D; Jones, N; Kamath, B; Ling, SC; Nalli, N; Naqvi, A; Ng, V; Weitzman, S | 1 |
| Guo, JW; Luo, XP; Ning, Q; Xi, D; Yan, WM | 1 |
| Cao, CZ; Cao, MM; Dong, L; Gao, YB; Ge, CH; Li, CY; Li, W; Peng, RY; Wang, QM; Wang, ZD; Xu, WX; Yang, F; Yang, XM; Yu, M; Zhan, YQ | 1 |
| Gao, S; Guo, J; Luo, X; Ning, Q; Wang, M; Wang, Z; Xi, D; Yan, W; Ye, H; Zhu, C | 1 |
| Calvaruso, V | 1 |
| Agarwal, B; Burroughs, A; Chowdary, P; Davenport, A; Gatt, A; Jalan, R; Mallett, S; Riddell, A; Vemala, V; Wright, G | 1 |
| Cao, D; Chen, Y; Fei, L; Guo, G; Ruan, Z; Wu, Y; Xie, Z; Xu, H | 1 |
| Crookshank, J; Cybulsky, M; Gorczynski, R; Grant, D; Levy, G; Liu, H; Manuel, J; Zhang, L | 1 |
13 other study(ies) available for fibrinogen and Liver Failure, Acute
| Article | Year |
|---|---|
Recombinant Human HPS Protects Mice and Nonhuman Primates from Acute Liver Injury.
Topics: Animals; CHO Cells; Cricetulus; Cytokines; Drug Evaluation, Preclinical; Fibrinogen; Galactosamine; Humans; Lipopolysaccharides; Liver Failure, Acute; Macaca fascicularis; Male; Mice, Inbred BALB C; Oxidative Stress; Random Allocation; Rats, Sprague-Dawley; Recombinant Proteins; Toxicity Tests, Acute | 2021 |
Performance of the Liver Maximum Function Capacity Test, Fibrinogen, and Transient Elastography in Patients with Acute Liver Injury.
Topics: Adult; Elasticity Imaging Techniques; Female; Fibrinogen; Humans; Liver Failure, Acute; Liver Function Tests; Male; Middle Aged; Retrospective Studies; Young Adult | 2023 |
Clara Cell 10 kDa Protein Alleviates Murine Hepatitis Virus Strain 3-Induced Fulminant Hepatitis by Inhibiting Fibrinogen-Like Protein 2 Expression.
Topics: Animals; CHO Cells; Coronavirus Infections; Cricetulus; Disease Models, Animal; Female; Fibrinogen; Hepatitis, Viral, Animal; High Mobility Group Proteins; Human Umbilical Vein Endothelial Cells; Humans; Liver; Liver Failure, Acute; Macrophages; Mice; Mice, Inbred BALB C; Murine hepatitis virus; Necrosis; Recombinant Proteins; Repressor Proteins; Survival Rate; THP-1 Cells; Uteroglobin | 2018 |
Combined adenovirus-mediated artificial microRNAs targeting mfgl2, mFas, and mTNFR1 protect against fulminant hepatic failure in mice.
Topics: Adenoviridae; Animals; Apoptosis; Caspase 3; CHO Cells; Cricetulus; Disease Models, Animal; fas Receptor; Female; Fibrin; Fibrinogen; Gene Expression Regulation; Genetic Vectors; Liver; Liver Failure, Acute; Mice; MicroRNAs; Plasmids; Receptors, Tumor Necrosis Factor, Type I; RNA Interference | 2013 |
C5a/C5aR pathway is essential for the pathogenesis of murine viral fulminant hepatitis by way of potentiating Fgl2/fibroleukin expression.
Topics: Acute Disease; Animals; Complement C5a; Female; Fibrinogen; Hepatitis, Viral, Animal; Humans; Liver Failure, Acute; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Murine hepatitis virus; Receptor, Anaphylatoxin C5a; Severity of Illness Index; Up-Regulation | 2014 |
Liver transplantation for children with acute liver failure associated with secondary hemophagocytic lymphohistiocytosis.
Topics: Adolescent; Biopsy; Child; Child, Preschool; Cross-Sectional Studies; Disease Progression; Female; Ferritins; Fibrinogen; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infant; Liver; Liver Failure, Acute; Liver Transplantation; Lymphohistiocytosis, Hemophagocytic; Male; Rare Diseases; Recurrence; Retrospective Studies; Survival Rate; Time-to-Treatment; Treatment Outcome; Triglycerides | 2016 |
[Establishment of pig acute liver failure model and the role of pig fibrinogen-like protein 2].
Topics: Animals; Disease Models, Animal; Fibrinogen; Galactosamine; Immunohistochemistry; Liver; Liver Failure, Acute; Liver Function Tests; Male; Polymerase Chain Reaction; Random Allocation; RNA, Messenger; Swine | 2009 |
Recombinant human hepassocin stimulates proliferation of hepatocytes in vivo and improves survival in rats with fulminant hepatic failure.
Topics: Animals; Apoptosis; Cell Proliferation; Cells, Cultured; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Fibrinogen; Hepatocytes; Humans; Liver Failure, Acute; Liver Regeneration; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neoplasm Proteins; Rats; Rats, Wistar; Recombinant Proteins; RNA Interference | 2010 |
Dual interference with novel genes mfgl2 and mTNFR1 ameliorates murine hepatitis virus type 3-induced fulminant hepatitis in BALB/cJ mice.
Topics: Animals; Apoptosis; Blotting, Western; CHO Cells; Cricetinae; Cricetulus; Disease Models, Animal; Female; Fibrinogen; Gene Expression; Hydrodynamics; Liver Failure, Acute; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Murine hepatitis virus; Receptors, Tumor Necrosis Factor, Type I; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Small Interfering; Thromboplastin; Transcription, Genetic | 2010 |
Hepassocin as a treatment for fulminant hepatic failure: will it translate from rats to human?
Topics: Animals; Disease Models, Animal; Fibrinogen; Humans; Liver Failure, Acute; Neoplasm Proteins; Rats; Recombinant Proteins; Species Specificity; Translational Research, Biomedical | 2010 |
Evaluation of coagulation abnormalities in acute liver failure.
Topics: Adult; Aged; Aged, 80 and over; Cell-Derived Microparticles; Factor VIII; Female; Fibrinogen; Hemorrhage; Hemostasis; Heparinoids; Humans; International Normalized Ratio; Liver Failure, Acute; Male; Middle Aged; Platelet Count; Prothrombin Time; Risk Factors; Thrombelastography; Thrombin; von Willebrand Factor | 2012 |
Intrahepatic expression of programmed death-1 and its ligands in patients with HBV-related acute-on-chronic liver failure.
Topics: Apoptosis; B7-H1 Antigen; Biomarkers; CD8-Positive T-Lymphocytes; End Stage Liver Disease; Epithelial Cells; Fibrinogen; Hepatitis B virus; Hepatitis B, Chronic; Humans; Killer Cells, Natural; Ligands; Liver; Liver Failure, Acute; Macrophages; Monocytes; Programmed Cell Death 1 Ligand 2 Protein; Programmed Cell Death 1 Receptor; Viral Load | 2013 |
Identification of the receptor for FGL2 and implications for susceptibility to mouse hepatitis virus (MHV-3)-induced fulminant hepatitis.
Topics: ADP-ribosyl Cyclase 1; Animals; Cell Line; Coronavirus Infections; Cricetinae; Fibrinogen; Liver Failure, Acute; Mice; Mice, Inbred C57BL; Murine hepatitis virus; Protein Binding; Receptors, IgG; Species Specificity; Spleen | 2006 |